122 related articles for article (PubMed ID: 31807984)
1. Prdx2 Upregulation Promotes the Growth and Survival of Gastric Cancer Cells.
Zhang S; He J; Tang M; Sun H
Pathol Oncol Res; 2020 Jul; 26(3):1869-1877. PubMed ID: 31807984
[TBL] [Abstract][Full Text] [Related]
2. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells.
Chen X; Zhao Y; Luo W; Chen S; Lin F; Zhang X; Fan S; Shen X; Wang Y; Liang G
Theranostics; 2020; 10(22):10290-10308. PubMed ID: 32929349
[No Abstract] [Full Text] [Related]
3. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer.
Wang S; Chen Z; Zhu S; Lu H; Peng D; Soutto M; Naz H; Peek R; Xu H; Zaika A; Xu Z; El-Rifai W
Redox Biol; 2020 Jan; 28():101319. PubMed ID: 31536951
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
7. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
8. Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer.
Kim B; Kim YS; Ahn HM; Lee HJ; Jung MK; Jeong HY; Choi DK; Lee JH; Lee SR; Kim JM; Lee DS
Int J Oncol; 2017 Jul; 51(1):298-306. PubMed ID: 28535004
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
[TBL] [Abstract][Full Text] [Related]
10. Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
Chuerduangphui J; Ekalaksananan T; Heawchaiyaphum C; Vatanasapt P; Pientong C
PLoS One; 2020; 15(12):e0242465. PubMed ID: 33332365
[TBL] [Abstract][Full Text] [Related]
11. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
Zheng X; Wei J; Li W; Li X; Wang W; Guo J; Fu Z
Aging (Albany NY); 2020 Jul; 12(16):16390-16409. PubMed ID: 32692719
[TBL] [Abstract][Full Text] [Related]
12. ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis.
Lu YX; Ju HQ; Liu ZX; Chen DL; Wang Y; Zhao Q; Wu QN; Zeng ZL; Qiu HB; Hu PS; Wang ZQ; Zhang DS; Wang F; Xu RH
Cancer Res; 2018 Apr; 78(8):1972-1985. PubMed ID: 29654155
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.
Bai B; Lin Y; Hu J; Wang H; Li L; Zhao S; Zhang J; Meng W; Yue P; Bai Z; Li X
Oncol Rep; 2019 Mar; 41(3):1539-1548. PubMed ID: 30747220
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer.
Xu DH; Li Q; Hu H; Ni B; Liu X; Huang C; Zhang ZZ; Zhao G
J Exp Clin Cancer Res; 2018 Dec; 37(1):308. PubMed ID: 30541591
[TBL] [Abstract][Full Text] [Related]
15. Induced nitric oxide synthetase and peroxiredoxin expression in intramucosal poorly differentiated gastric cancer of young patients.
Hirahashi M; Koga Y; Kumagai R; Aishima S; Taguchi K; Oda Y
Pathol Int; 2014 Apr; 64(4):155-63. PubMed ID: 24750185
[TBL] [Abstract][Full Text] [Related]
16. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
Wang W; Wei J; Zhang H; Zheng X; Zhou H; Luo Y; Yang J; Deng Q; Huang S; Fu Z
Cell Death Dis; 2021 Jun; 12(6):605. PubMed ID: 34117220
[TBL] [Abstract][Full Text] [Related]
17. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
18. Silencing of PRDX2 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells.
Jing X; Du L; Niu A; Wang Y; Wang Y; Wang C
Biomed Res Int; 2020; 2020():1276328. PubMed ID: 32337219
[TBL] [Abstract][Full Text] [Related]
19. YEATS Domain Containing 4 Promotes Gastric Cancer Cell Proliferation and Mediates Tumor Progression via Activating the Wnt/β-Catenin Signaling Pathway.
Ji S; Zhang Y; Yang B
Oncol Res; 2017 Nov; 25(9):1633-1641. PubMed ID: 28251887
[TBL] [Abstract][Full Text] [Related]
20. PRDX2 in Myocyte Hypertrophy and Survival is Mediated by TLR4 in Acute Infarcted Myocardium.
Jin X; Chen C; Li D; Su Q; Hang Y; Zhang P; Hu W
Sci Rep; 2017 Aug; 7(1):6970. PubMed ID: 28765537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
